113
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study

, , , , &
Pages 1515-1523 | Published online: 19 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Katarina Rukavina, Lucia Batzu, Alexandra Boogers, Arturo Abundes-Corona, Veronica Bruno & K Ray Chaudhuri. (2021) Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs. Expert Review of Neurotherapeutics 21:3, pages 335-352.
Read now
Jens Laigaard, Nina Bache, Stefan Stottmeier, Ole Mathiesen & Stine Estrup. (2020) Cognitive Function During Opioid Tapering in Patients with Chronic Pain: A Prospective Cohort Study. Journal of Pain Research 13, pages 3385-3394.
Read now
Michael J. Brennan & Jeffrey A. Gudin. (2020) The prescription opioid conundrum: 21st century solutions to a millennia-long problem. Postgraduate Medicine 132:1, pages 17-27.
Read now
Fabio Guerriero & M. Carrington Reid. (2017) New opioid prescribing guidelines released in the US: what impact will they have in the care of older patients with persistent pain?. Current Medical Research and Opinion 33:2, pages 275-278.
Read now

Articles from other publishers (18)

Nariman Essmat, Dávid Árpád Karádi, Ferenc Zádor, Kornél Király, Susanna Fürst & Mahmoud Al-Khrasani. (2023) Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis. Molecules 28:23, pages 7766.
Crossref
Jennifer Corcoran, Andrew H. Huang, Janis M. Miyasaki & Christopher G. Tarolli. 2023. Neuropalliative Care, Part II. Neuropalliative Care, Part II 107 128 .
Aaron K. Wong, Anneke Grobler & Brian Le. (2022) ENhANCE trial protocol: A multi-centre, randomised, phase IV trial comparing the efficacy of oxycodone/naloxone prolonged release (OXN PR) versus oxycodone prolonged release (Oxy PR) tablets in patients with advanced cancer. Contemporary Clinical Trials Communications 30, pages 101036.
Crossref
Malinee Neelamegam, Janice Zgibor, Henian Chen, Kathleen O’rourke, Chighaf Bakour, Lakshminarayan Rajaram & Kaarin J Anstey. (2021) The effect of opioids on the cognitive function of older adults: results from the Personality and Total Health through life study. Age and Ageing 50:5, pages 1699-1708.
Crossref
Ulderico Freo, Maurizio Furnari, Francesco Ambrosio & Paolo Navalesi. (2020) Efficacy and tolerability of tapentadol for the treatment of chronic low back pain in elderly patients. Aging Clinical and Experimental Research 33:4, pages 973-982.
Crossref
Rong Ouyang, Zhongzhuan Li, Shijiang Huang, Jun Liu & Jiean Huang. (2020) Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis. Pain Medicine 21:11, pages 3224-3232.
Crossref
Sophie Pask, Myriam Dell'Olio, Fliss E.M. Murtagh & Jason W. Boland. (2020) The Effects of Opioids on Cognition in Older Adults With Cancer and Chronic Noncancer Pain: A Systematic Review. Journal of Pain and Symptom Management 59:4, pages 871-893.e1.
Crossref
Melissa Jassal, Greg Egan & Karen Dahri. (2019) Opioid Prescribing in the Elderly: A Systematic Review. Journal of Pharmacy Technology 36:1, pages 28-40.
Crossref
Richard J. Bodnar. (2020) Endogenous opiates and behavior: 2017. Peptides 124, pages 170223.
Crossref
Albert Lukas, Ulrich Hagg-Grün, Benjamin Mayer, Thomas Flscher & Matthias Schuler. (2019) REPRINTED WITH PERMISSION OF IASP – Pain assessment in advanced dementia. Validity of the German PAINAD – a prospective double-blind randomised placebo-controlled trial. BÓL 19:4, pages 34-49.
Crossref
Albert Lukas, Ulrich Hagg-Grün, Benjamin Mayer, Thomas Fischer & Matthias Schuler. (2018) Pain assessment in advanced dementia. Validity of the German PAINAD—a prospective double-blind randomised placebo-controlled trial. Pain 160:3, pages 742-753.
Crossref
Klaus Seppi, K. Ray Chaudhuri, Miguel Coelho, Susan H. Fox, Regina Katzenschlager, Santiago Perez Lloret, Daniel Weintraub & Cristina Sampaio. (2019) Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review. Movement Disorders 34:2, pages 180-198.
Crossref
Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean-Luc Raoul, Peter Schirmacher & Valérie Vilgrain. (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 69:1, pages 182-236.
Crossref
Salomão Antônio Olivência, Luiza Gabriela Mendes Barbosa, Marcela Rodrigues da Cunha & Ledismar José da Silva. (2018) Pharmacological treatment of chronic non-malignant pain among elderly persons: an integrative review. Revista Brasileira de Geriatria e Gerontologia 21:3, pages 372-381.
Crossref
Bart J. Morlion, Stefan A. Mueller‐Lissner, Renato Vellucci, Wojciech Leppert, Benoît C. Coffin, Sara L. Dickerson & Tony O'Brien. (2017) Oral Prolonged‐Release Oxycodone/Naloxone for Managing Pain and Opioid‐Induced Constipation: A Review of the Evidence. Pain Practice 18:5, pages 647-665.
Crossref
Francesco Tovoli, Stefania De Lorenzo, Boaz G. Samolsky Dekel, Fabio Piscaglia, Francesca Benevento, Giovanni Brandi & Luigi Bolondi. (2017) Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma. Liver International 38:2, pages 278-284.
Crossref
Magdalena Kocot-KępskaRenata ZajączkowskaAnna Przeklasa-MuszyńskaJan Dobrogowski. (2017) The role of oxycodone/naloxone in pain management. BÓL 17:4, pages 26-40.
Crossref
Fabio Guerriero. (2017) Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults. World Journal of Clinical Cases 5:3, pages 73.
Crossref